Eukles Asset Management’s Merck MRK Stock Holding History

Eukles Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.78K	Hold	45	–	–	﹤0.01%	169
2026 Q1	$5.41K	Hold	45	–	–	﹤0.01%	165
2025 Q4	$4.74K	Hold	45	–	–	﹤0.01%	186
2025 Q3	$3.78K	Hold	45	–	–	﹤0.01%	191
2025 Q2	$3.56K	Hold	45	–	–	﹤0.01%	194
2025 Q1	$4.04K	Hold	45	–	–	﹤0.01%	177
2024 Q4	$4.48K	Hold	45	–	–	﹤0.01%	183
2024 Q3	$5.11K	Hold	45	–	–	﹤0.01%	182
2024 Q2	$5.57K	Hold	45	–	–	﹤0.01%	170
2024 Q1	$5.94K	Hold	45	–	–	﹤0.01%	170
2023 Q4	$4.91K	Hold	45	–	–	﹤0.01%	178
2023 Q3	$4.63K	Hold	45	–	–	﹤0.01%	178
2023 Q2	$5.19K	Hold	45	–	–	﹤0.01%	167
2023 Q1	$4.79K	Hold	45	–	–	﹤0.01%	163
2022 Q4	$5K	Hold	45	–	–	﹤0.01%	159
2022 Q3	$4K	Hold	45	–	–	﹤0.01%	167
2022 Q2	$4K	Hold	45	–	–	﹤0.01%	165
2022 Q1	$4K	Hold	45	–	–	﹤0.01%	170
2021 Q4	$3K	Hold	45	–	–	﹤0.01%	194
2021 Q3	$3K	Hold	45	–	–	﹤0.01%	183
2021 Q2	$3K	Sell	45 -2	-4%	-$149	﹤0.01%	209
2021 Q1	$3K	Buy	+47	New	+$3.47K	﹤0.01%	179

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Eukles Asset Management's MRK Position: Q2 2026 in Review

Eukles Asset Management held its Merck (MRK) position steady in Q2 2026 at 45 shares worth $5.78K. The position accounts for ﹤0.01% of the portfolio, ranked #169.

Eukles Asset Management first reported a position in MRK in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.94K in Q1 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Eukles Asset Management held 45 shares of Merck worth $5.78K as of Q2 2026.
Eukles Asset Management left its Merck share count unchanged in Q2 2026.
Merck made up ﹤0.01% of Eukles Asset Management's portfolio in Q2 2026, its #169 holding.
Eukles Asset Management first reported a position in Merck in Q1 2021 and has held it in 22 quarters since.
Eukles Asset Management's Merck position peaked at $5.94K in Q1 2024.
3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Eukles Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.